Eli Lilly and Co (WBO:LLYC)
€ 998.2 -11.6 (-1.15%) Market Cap: 905.70 Bil Enterprise Value: 939.15 Bil PE Ratio: 41.09 PB Ratio: 33.13 GF Score: 86/100

Eli Lilly and Co to Discuss ESMO 2019 Presentations - Conference Call Transcript

Oct 02, 2019 / 01:00PM GMT
Release Date Price: €98 (-4.85%)

Oct 02, 2019 / 01:00PM GMT
Presentations - Conference Call
Oct 02, 2019 / 01:00PM GMT

=====================
Corporate Participants
=====================
* Anne E. White
Eli Lilly and Company - Senior VP & President of Lilly Oncology
* Daniel M. Skovronsky
Eli Lilly and Company - Senior VP & Chief Scientific Officer
* Jacob S. Van Naarden
Loxo Oncology, Inc. - COO
* Kim Macko
* Martin Frenzel
* Maura Dickler
* S. Michael Rothenberg

=====================
Conference Call Participants
=====================
* Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD
* Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
* Seamus Christopher Fernandez
Guggenheim Securities, LLC, Research Division - Senior Analyst of Global Pharmaceuticals
* Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot